Trial Profile

Expanded Access to NanoPac

Status: Recruiting

Phase of Trial: Clinical Phase Unknown

Latest Information Update: 04 Jul 2025

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Paclitaxel (Primary)
Indications Actinic keratosis; Cervical intraepithelial neoplasia; Non-small cell lung cancer; Ovarian cancer; Pancreatic cancer; Pancreatic disorders; Plaque psoriasis; Prostate cancer; Skin cancer
Focus Expanded access; Therapeutic Use
Sponsors Nanology

Most Recent Events

09 May 2023 Results (N=6)evaluating the immediate response and durability of response following EUS FNI of BD IPMN, presented at the Digestive Disease Week 2023
04 Dec 2018 New trial record

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com